Creative Biolabs-Immuno-oncology

Anti-CD44v6 (clone BIWA-8P) SynExpress T7-mKa-cJ-X Modified CD8+ T cells (CAT#: ITS-1224-CR1613)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD44v6 (clone BIWA-8P). We employs the pBR322 (T7-mKate-c-Jun-XbaI) vector components and the SynExpress system of the lncRNA Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD44v6
Clone
BIWA-8P
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
T7
Effector Gene
c-Jun
Insertion Sites
XbaI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
pBR322
Transformation Accuracy
0.92
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.